Enlivex (ENLV)

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

的Enlivex Ltd. Ordinary Shares（ENLV）股票after-hours的价格今天是$1.14，自市场最后关闭以来，反映出-2.99%after-hours的变动。该公司市值为$2.69亿，日交易量为$19.90万股。对于关注价格走势的投资者来说，Enlivex Ltd. Ordinary Shares股票今日的波动区间在$1.12和$1.16之间。前一交易日收盘价为 $1.17。

您准备好开始了吗？按照以下步骤操作，或阅读我们关于在Kraken上从10美元起购买Enlivex股票的指南。